Sign in
PHXM Stock Price, Chart, Stats & News
PHAXIAM Therapeutics S.A.
Save
19.86M
Market cap
–
Current P/E
–
Forward P/E
PHXM chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 5.04% |
ROA | -45.78% |
ROE | -95.68% |
D/E | 0.43x |
Interest coverage ratio | -129.68x |
PHXM valuation
P/E | – |
P/S | – |
P/B | 0.53x |
P/CF | -0.56x |
P/FCF | -0.70x |
P/OCF | -0.56x |
PEG | -0.01x |
EV multiple | -0.73x |
About
PHAXIAM Therapeutics S. A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U. S.
Similar securities
Based on sector and market capitalization
Report issue